Pheochromocytoma/paraganglioma syndrome 5: genes and variants
Explore variant evidence for Pheochromocytoma/paraganglioma syndrome 5 across 5 analyzed proteins (SDHB, SDHC, SDHA, SDHD, SDHAF2). Linked ClinVar records include 82 pathogenic or likely pathogenic variants, 1,625 variants of uncertain significance and 177 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pheochromocytoma/paraganglioma syndrome 5
SDHB: Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
It transfers electrons from succinate oxidation through iron-sulfur centers toward ubiquinone in mitochondrial complex II. Heterozygous loss-of-function variants strongly predispose to paraganglioma and pheochromocytoma and can also increase renal-tumor and gastrointestinal-stromal-tumor risk.
48 ClinVar pathogenic / likely pathogenic and 428 uncertain variants in SDHB have source records linked to Pheochromocytoma/paraganglioma syndrome 5. Association strength is not clinical gene validity.
SDHC: Succinate dehydrogenase cytochrome b560 subunit, mitochondrial
It anchors succinate dehydrogenase to the inner mitochondrial membrane and helps transfer electrons from the catalytic subunits to ubiquinone. Heterozygous loss-of-function variants predispose to paraganglioma, pheochromocytoma, and some gastrointestinal stromal tumors.
16 ClinVar pathogenic / likely pathogenic and 256 uncertain variants in SDHC have source records linked to Pheochromocytoma/paraganglioma syndrome 5. Association strength is not clinical gene validity.
SDHA: Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
It catalyzes oxidation of succinate to fumarate while transferring electrons into respiratory-chain complex II, directly linking the TCA cycle with oxidative phosphorylation. Biallelic deficiency can cause mitochondrial disease, while heterozygous loss-of-function variants predispose to paraganglioma, pheochromocytoma, and selected gastrointestinal stromal tumors.
14 ClinVar pathogenic / likely pathogenic and 1,084 uncertain variants in SDHA have source records linked to Pheochromocytoma/paraganglioma syndrome 5. Association strength is not clinical gene validity.
SDHD: Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
It provides a membrane-anchoring component of succinate dehydrogenase and is required for normal complex II electron transfer. Germline loss-of-function variants, often showing a parent-of-origin effect, strongly predispose to head-and-neck paragangliomas and pheochromocytomas.
4 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in SDHD have source records linked to Pheochromocytoma/paraganglioma syndrome 5. Association strength is not clinical gene validity.
SDHAF2: Succinate dehydrogenase assembly factor 2, mitochondrial
It is required for covalent flavin attachment and maturation of the SDHA catalytic subunit, enabling normal succinate dehydrogenase activity. Germline loss-of-function variants can predispose to hereditary head-and-neck paragangliomas through functional loss of complex II.
0 ClinVar pathogenic / likely pathogenic and 30 uncertain variants in SDHAF2 have source records linked to Pheochromocytoma/paraganglioma syndrome 5. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Pheochromocytoma/paraganglioma syndrome 5
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SDHA R585Q | 585 | Pathogenic / likely pathogenic (★★) | |
| SDHB R46L | 46 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C196Y | 196 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB P197R | 197 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB P197S | 197 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB R217G | 217 | Interaction with SDHAF1 | Pathogenic / likely pathogenic (★★) |
| SDHB R217L | 217 | Interaction with SDHAF1 | Pathogenic / likely pathogenic (★★) |
| SDHB R230L | 230 | Pathogenic / likely pathogenic (★★) | |
| SDHB R242C | 242 | Pathogenic / likely pathogenic (★★) | |
| SDHB R242S | 242 | Pathogenic / likely pathogenic (★★) | |
| SDHA R585W | 585 | Pathogenic / likely pathogenic (★★) | |
| SDHB R46G | 46 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB D74A | 74 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C93R | 93 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C93Y | 93 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB D138Y | 138 | Pathogenic / likely pathogenic (★★) | |
| SDHB C189Y | 189 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C189F | 189 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB R217S | 217 | Interaction with SDHAF1 | Pathogenic / likely pathogenic (★★) |
| SDHB R230C | 230 | Pathogenic / likely pathogenic (★★) | |
| SDHB R242H | 242 | Pathogenic / likely pathogenic (★★) | |
| SDHC R72H | 72 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHC R72C | 72 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHC H127R | 127 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHC H127Y | 127 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHC H127N | 127 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHA M1K | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHA G439E | 439 | Pathogenic / likely pathogenic (★★) | |
| SDHB M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHB K40E | 40 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB G96D | 96 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB W200R | 200 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C253Y | 253 | Pathogenic / likely pathogenic (★★) | |
| SDHC M1R | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHC R72L | 72 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHC R72G | 72 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHA M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHA M1L | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHA R554W | 554 | Pathogenic / likely pathogenic (★★) | |
| SDHA R589G | 589 | Pathogenic / likely pathogenic (★★) | |
| SDHB M1L | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHB M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHB A43P | 43 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C98Y | 98 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB G99D | 99 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB H132P | 132 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB V140F | 140 | Pathogenic / likely pathogenic (★★) | |
| SDHB C191Y | 191 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C192Y | 192 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB G208R | 208 | Interaction with SDHAF1 | Pathogenic / likely pathogenic (★★) |
| SDHB G208E | 208 | Interaction with SDHAF1 | Pathogenic / likely pathogenic (★★) |
| SDHB Q214R | 214 | Interaction with SDHAF1 | Pathogenic / likely pathogenic (★★) |
| SDHB C243W | 243 | Pathogenic / likely pathogenic (★★) | |
| SDHC M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHC R50C | 50 | Mitochondrial matrix | Pathogenic / likely pathogenic (★★) |
| SDHC G75D | 75 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHC Y126C | 126 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHA G260R | 260 | Pathogenic / likely pathogenic (★★) | |
| SDHA A454E | 454 | Pathogenic / likely pathogenic (★★) | |
| SDHB N248K | 248 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 82.
Uncertain variants prioritized for review in Pheochromocytoma/paraganglioma syndrome 5
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SDHB W200C | 200 | 4Fe-4S ferredoxin-type | Conflicting reports (★) | +7: 3 other pathogenic changes within 3 positions; W200R at the same position is pathogenic; seen in 6.8e-06 of gnomAD DNA copies; REVEL 0.925 |
| SDHA R589Q | 589 | Conflicting reports (★) | +7: in a 3D region that tolerates change poorly (1R); R589G at the same position is pathogenic; seen in 2.7e-06 of gnomAD DNA copies; REVEL 0.942 | |
| SDHB Q214H | 214 | Interaction with SDHAF1 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; Q214R at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.891 |
| SDHA G439R | 439 | Uncertain (★) | +7: in a 3D region that tolerates change poorly (1R); G439E at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.947 | |
| SDHA G555R | 555 | Uncertain (★★) | +7: 2 other pathogenic changes within 3 positions; G555E at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.889 | |
| SDHB H132R | 132 | 2Fe-2S ferredoxin-type | Uncertain (★★) | +7: in a 3D region that tolerates change poorly (1R); H132P at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.896 |
| SDHA R554P | 554 | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; R554W at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.836 | |
| SDHB V140D | 140 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; V140F at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| SDHB C192S | 192 | 4Fe-4S ferredoxin-type | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; C192Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SDHB C113G | 113 | 2Fe-2S ferredoxin-type | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; C113S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| SDHB C93F | 93 | 2Fe-2S ferredoxin-type | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; C93R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SDHB C189R | 189 | 4Fe-4S ferredoxin-type | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; C189W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SDHB G96V | 96 | 2Fe-2S ferredoxin-type | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; G96D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SDHB K40N | 40 | 2Fe-2S ferredoxin-type | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; K40E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| SDHB R217H | 217 | Interaction with SDHAF1 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; R217S at the same position is pathogenic; REVEL 0.957 |
| SDHB C68R | 68 | 2Fe-2S ferredoxin-type | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; C68Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| SDHB C186R | 186 | 4Fe-4S ferredoxin-type | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; C186Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SDHB C186S | 186 | 4Fe-4S ferredoxin-type | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; C186Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SDHB P197L | 197 | 4Fe-4S ferredoxin-type | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; P197R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| SDHB G99S | 99 | 2Fe-2S ferredoxin-type | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; G99D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| SDHB G96R | 96 | 2Fe-2S ferredoxin-type | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; G96D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SDHB W200G | 200 | 4Fe-4S ferredoxin-type | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; W200R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.96 |
| SDHC R50L | 50 | Mitochondrial matrix | Uncertain (★★) | +6: R50C at the same position is pathogenic; REVEL 0.956 |
| SDHB D74N | 74 | 2Fe-2S ferredoxin-type | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; D74G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| SDHC R50H | 50 | Mitochondrial matrix | Uncertain (★★) | +6: R50C at the same position is pathogenic; REVEL 0.945 |
| SDHA R554L | 554 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; R554W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.84 |
Which prediction tools work for Pheochromocytoma/paraganglioma syndrome 5
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 95 out of 100
- MetaLR: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 93 out of 100
- ESM1b (LLR): 92 out of 100
- AlphaMissense: 92 out of 100
- phyloP: 90 out of 100
- Pangolin: 49 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 47 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Carney-Stratakis syndrome also has ClinVar records linked to SDHB variants; they fall in the same places as the Pheochromocytoma/paraganglioma syndrome 5 variants (7 pathogenic / likely pathogenic).
- Mitochondrial complex 2 deficiency, nuclear also has ClinVar records linked to SDHB variants; they fall in the same places as the Pheochromocytoma/paraganglioma syndrome 5 variants (7 pathogenic / likely pathogenic).
- Inherited phaeochromocytoma and paraganglioma excluding NF1 also has ClinVar records linked to SDHB variants; they fall partly in the same places as the Pheochromocytoma/paraganglioma syndrome 5 variants (4 pathogenic / likely pathogenic).
- Mitochondrial complex II deficiency, nuclear also has ClinVar records linked to SDHA variants; they fall partly in the same places as the Pheochromocytoma/paraganglioma syndrome 5 variants (18 pathogenic / likely pathogenic).
- Pheochromocytoma also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Pheochromocytoma/paraganglioma syndrome 5 variants (14 pathogenic / likely pathogenic).
- Paragangliomas with sensorineural hearing loss also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Pheochromocytoma/paraganglioma syndrome 5 variants (13 pathogenic / likely pathogenic).
- Carney-Stratakis syndrome also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Pheochromocytoma/paraganglioma syndrome 5 variants (11 pathogenic / likely pathogenic).
- Cowden syndrome also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Pheochromocytoma/paraganglioma syndrome 5 variants (11 pathogenic / likely pathogenic).
Diseases related to Pheochromocytoma/paraganglioma syndrome 5
- Hereditary pheochromocytoma and paraganglioma, also linked to SDHA, SDHAF2, SDHB, SDHC and 1 more
- Gastrointestinal stromal tumor, also linked to SDHA, SDHB and SDHC
- Carney-Stratakis syndrome, also linked to SDHB, SDHC and SDHD
- Inherited phaeochromocytoma and paraganglioma excluding NF1, also linked to SDHA, SDHB and SDHC
- Pheochromocytoma, also linked to SDHB and SDHD
- Mitochondrial complex II deficiency, nuclear, also linked to SDHA and SDHD
- Mitochondrial complex 2 deficiency, nuclear, also linked to SDHB and SDHD
- Cowden syndrome, also linked to SDHD
- Paragangliomas with sensorineural hearing loss, also linked to SDHD
- Neurodegeneration with ataxia and late-onset optic atrophy, also linked to SDHA
- Dilated cardiomyopathy 1GG, also linked to SDHA
- Familial isolated dilated cardiomyopathy, also linked to SDHA
Frequently asked questions
Which genes have records linked to Pheochromocytoma/paraganglioma syndrome 5?
This view contains 5 analyzed proteins: SDHB, SDHC, SDHA, SDHD, SDHAF2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 82 pathogenic or likely pathogenic variants, 1,625 variants of uncertain significance and 177 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 26 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,970 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center